• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

登革4型病毒的近原子分辨率冷冻电子显微镜结构

Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus.

作者信息

Kostyuchenko Victor A, Chew Pau Ling, Ng Thiam-Seng, Lok Shee-Mei

机构信息

Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore.

出版信息

J Virol. 2014 Jan;88(1):477-82. doi: 10.1128/JVI.02641-13. Epub 2013 Oct 23.

DOI:10.1128/JVI.02641-13
PMID:24155405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3911750/
Abstract

Dengue virus (DENV), a mosquito-borne virus, is responsible for millions of cases of infections worldwide. There are four DENV serotypes (DENV1 to -4). After a primary DENV infection, the antibodies elicited confer lifetime protection against that DENV serotype. However, in a secondary infection with another serotype, the preexisting antibodies may cause antibody-dependent enhancement (ADE) of infection of macrophage cells, leading to the development of the more severe form of disease, dengue hemorrhagic fever. Thus, a safe vaccine should stimulate protection against all dengue serotypes simultaneously. To facilitate the development of a vaccine, good knowledge of different DENV serotype structures is crucial. Structures of DENV1 and DENV2 had been solved previously. Here we present a near-atomic resolution cryo-electron microscopy (cryo-EM) structure of mature DENV4. Comparison of the DENV4 structure with similar-resolution cryo-EM structures of DENV1 and DENV2 showed differences in surface charge distribution, which may explain their differences in binding to cellular receptors, such as heparin. Also, observed variations in amino acid residues involved in interactions between envelope and membrane proteins on the virus surface correlate with their ability to undergo structural changes at higher temperatures.

摘要

登革病毒(DENV)是一种蚊媒病毒,在全球范围内导致数百万例感染病例。有四种登革病毒血清型(DENV1至DENV4)。初次感染登革病毒后,所产生的抗体可提供针对该血清型的终身保护。然而,在再次感染另一种血清型时,先前存在的抗体可能会导致巨噬细胞感染的抗体依赖性增强(ADE),从而引发更严重的疾病形式——登革出血热。因此,一种安全的疫苗应能同时刺激针对所有登革病毒血清型的保护作用。为促进疫苗的研发,深入了解不同登革病毒血清型的结构至关重要。登革病毒1型和2型的结构此前已得到解析。在此,我们展示了成熟登革病毒4型的近原子分辨率冷冻电子显微镜(cryo-EM)结构。将登革病毒4型的结构与登革病毒1型和2型具有相似分辨率的冷冻电子显微镜结构进行比较,结果显示表面电荷分布存在差异,这可能解释了它们在与细胞受体(如肝素)结合方面的差异。此外,观察到的病毒表面包膜蛋白与膜蛋白之间相互作用所涉及的氨基酸残基的变化,与其在较高温度下发生结构变化的能力相关。

相似文献

1
Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus.登革4型病毒的近原子分辨率冷冻电子显微镜结构
J Virol. 2014 Jan;88(1):477-82. doi: 10.1128/JVI.02641-13. Epub 2013 Oct 23.
2
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.绘制人类记忆B细胞和血清中和抗体对登革病毒4型感染及疫苗接种的反应图谱。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.
3
The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.由登革热候选疫苗引起的针对特定型别的中和抗体反应集中在包膜蛋白的两个氨基酸上。
PLoS Pathog. 2013;9(12):e1003761. doi: 10.1371/journal.ppat.1003761. Epub 2013 Dec 5.
4
A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.登革病毒2型上的一种新的四级结构表位是持久型特异性中和抗体的靶点。
mBio. 2015 Oct 13;6(5):e01461-15. doi: 10.1128/mBio.01461-15.
5
Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.用人免疫球蛋白 M 与登革病毒 4 种血清型的人工同源二聚体探测结构域 III 对其进行交叉反应研究。
BMC Infect Dis. 2013 Jul 1;13:302. doi: 10.1186/1471-2334-13-302.
6
The structural basis for serotype-specific neutralization of dengue virus by a human antibody.人类抗体对登革热病毒血清型特异性中和作用的结构基础。
Sci Transl Med. 2012 Jun 20;4(139):139ra83. doi: 10.1126/scitranslmed.3003888.
7
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.登革热病毒中和及抗体依赖增强活性的人源单克隆抗体来源于二次感染急性期的登革热患者。
Antiviral Res. 2013 Jun;98(3):423-31. doi: 10.1016/j.antiviral.2013.03.018. Epub 2013 Mar 29.
8
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.一种经包膜修饰的四价登革病毒样颗粒疫苗对黄病毒疫苗设计具有启示意义。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.
9
Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.通用登革热疫苗可诱导针对所有四种登革病毒血清型的中和抗体。
J Virol. 2021 Jan 28;95(4). doi: 10.1128/JVI.00658-20.
10
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.在小鼠模型中,抗体在针对登革病毒二次感染的异源保护中比免疫细胞发挥着更大的作用。
Virology. 2008 Oct 25;380(2):296-303. doi: 10.1016/j.virol.2008.08.008. Epub 2008 Sep 6.

引用本文的文献

1
Exploiting host kinases to combat dengue virus infection and disease.利用宿主激酶对抗登革病毒感染及疾病。
Antiviral Res. 2025 May 8;241:106172. doi: 10.1016/j.antiviral.2025.106172.
2
Validation of flavivirus infectious clones carrying fluorescent markers for antiviral drug screening and replication studies.携带荧光标记的黄病毒感染性克隆用于抗病毒药物筛选和复制研究的验证
Front Microbiol. 2023 Sep 15;14:1201640. doi: 10.3389/fmicb.2023.1201640. eCollection 2023.
3
B-cell epitope discovery: The first protein flexibility-based algorithm-Zika virus conserved epitope demonstration.B 细胞表位发现:首个基于蛋白质柔性的算法——寨卡病毒保守表位展示。
PLoS One. 2023 Mar 15;18(3):e0262321. doi: 10.1371/journal.pone.0262321. eCollection 2023.
4
Self-assembly of dengue virus empty capsid-like particles in solution.登革病毒空衣壳样颗粒在溶液中的自组装。
iScience. 2023 Feb 14;26(3):106197. doi: 10.1016/j.isci.2023.106197. eCollection 2023 Mar 17.
5
In Silico Comparative Analysis of Predicted B Cell Epitopes against Dengue Virus (Serotypes 1-4) Isolated from the Philippines.对从菲律宾分离出的登革热病毒(血清型1 - 4)预测的B细胞表位进行计算机模拟比较分析。
Vaccines (Basel). 2022 Aug 5;10(8):1259. doi: 10.3390/vaccines10081259.
6
The interaction of dengue virus capsid protein with negatively charged interfaces drives the in vitro assembly of nucleocapsid-like particles.登革病毒外壳蛋白与带负电荷的界面相互作用驱动核衣壳样颗粒的体外组装。
PLoS One. 2022 Mar 1;17(3):e0264643. doi: 10.1371/journal.pone.0264643. eCollection 2022.
7
Morphological Diversity and Dynamics of Dengue Virus Affecting Antigenicity.登革热病毒的形态多样性和动态变化影响其抗原性。
Viruses. 2021 Jul 24;13(8):1446. doi: 10.3390/v13081446.
8
Flavivirus: From Structure to Therapeutics Development.黄病毒:从结构到治疗药物研发
Life (Basel). 2021 Jun 25;11(7):615. doi: 10.3390/life11070615.
9
AXL, an Important Host Factor for DENV and ZIKV Replication.AXL 是登革热病毒和寨卡病毒复制的重要宿主因子。
Front Cell Infect Microbiol. 2021 Mar 22;11:575346. doi: 10.3389/fcimb.2021.575346. eCollection 2021.
10
Structure-guided paradigm shifts in flavivirus assembly and maturation mechanisms.结构导向的黄病毒组装和成熟机制的范式转变。
Adv Virus Res. 2020;108:33-83. doi: 10.1016/bs.aivir.2020.08.003. Epub 2020 Sep 23.

本文引用的文献

1
Immature and mature dengue serotype 1 virus structures provide insight into the maturation process.不成熟和成熟的登革热血清型 1 病毒结构提供了对成熟过程的深入了解。
J Virol. 2013 Jul;87(13):7700-7. doi: 10.1128/JVI.00197-13. Epub 2013 May 1.
2
Structural changes in dengue virus when exposed to a temperature of 37°C.登革热病毒在 37°C 温度下暴露时的结构变化。
J Virol. 2013 Jul;87(13):7585-92. doi: 10.1128/JVI.00757-13. Epub 2013 May 1.
3
Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion.登革病毒 2 型包膜蛋白硫酸乙酰肝素结合位点或 III 区侧嵴域突变可在膜融合前阻断病毒在 Vero 细胞中的复制。
Virology. 2013 Jul 5;441(2):114-25. doi: 10.1016/j.virol.2013.03.011. Epub 2013 Apr 6.
4
Dengue structure differs at the temperatures of its human and mosquito hosts.登革热结构在其人类和蚊子宿主的温度下有所不同。
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6795-9. doi: 10.1073/pnas.1304300110. Epub 2013 Apr 8.
5
The global distribution and burden of dengue.登革热的全球分布和负担。
Nature. 2013 Apr 25;496(7446):504-7. doi: 10.1038/nature12060. Epub 2013 Apr 7.
6
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].缺乏 Fcγ 受体结合的抗体对致死性登革病毒感染的治疗效果归因于中和效力和阻断增强抗体[更正]。
PLoS Pathog. 2013 Feb;9(2):e1003157. doi: 10.1371/journal.ppat.1003157. Epub 2013 Feb 14.
7
Cryo-EM structure of the mature dengue virus at 3.5-Å resolution.成熟登革热病毒的 3.5Å 分辨率冷冻电镜结构。
Nat Struct Mol Biol. 2013 Jan;20(1):105-10. doi: 10.1038/nsmb.2463. Epub 2012 Dec 16.
8
Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.涉及人体中抗体依赖性增强登革热病毒感染的分子机制。
Traffic. 2013 Jan;14(1):25-35. doi: 10.1111/tra.12012. Epub 2012 Oct 22.
9
Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century.登革热、城市化与全球化:21世纪的邪恶三位一体。
Trop Med Health. 2011 Dec;39(4 Suppl):3-11. doi: 10.2149/tmh.2011-S05. Epub 2011 Aug 25.
10
Dengue.登革热
N Engl J Med. 2012 Apr 12;366(15):1423-32. doi: 10.1056/NEJMra1110265.